Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia

Authors

  • Sazlyna Mohd Sazlly Lim Department of Medicine, Faculty of Medicine and Health Sciences, Universiti PutraMalaysia, 43400 Serdang, Selangor D. E., Malaysia.

Keywords:

hepatitis B, Lamivudine, adverse effect, rhabdomyolysis

Abstract

Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B. This paper presents a case of Lamivudine-associated rhabdomyolysis in a 31-year-old man with congenital heart disease and hepatitis B. Three days after starting Lamivudine, the patient developed myalgia. Significant muscle tenderness and swelling of the upper and lower limbs was discovered during a physical examination. Creatine kinase was markedly raised. Lamivudine-induced rhabdomyolysis was suspected and the drug was discontinued. Symptoms and creatine kinase activity improved within four days of Lamivudine cessation and hydration. Early identification of Lamivudine-induced rhabdomyolysis is key in preventing this potentially fatal drug reaction; withdrawal of Lamivudine may contribute to complete remission of rhabdomyolysis.

References

Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients.Medicine (Baltimore). 2005;84(6):377–85. PubMed PMID: 16267412.http://dx.doi.org/10.1097/01.md.0000188565.48918.412.Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009;67(9):272–83. PubMed PMID:19841484.3.Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72.PubMed PMID: 19571284.http://dx.doi.org/10.1056/NEJMra0801327.4.Better OS, Abassi ZA. Early fluid resuscitation in patients with rhabdomyolysis. Nat Rev Nephrol.2011;7(7):416–22. PubMed PMID: 21587227.http://dx.doi.org/10.1038/nrneph.2011.56.5.Mendila M, Walter GF, Stoll M, Schmidt RE. [Rhabdomyolysis in antiretroviral therapy with Lamivudin].Dtsch Med Wochenschr. 1997;122(33):1003–6. PubMed PMID: 9296927.http://dx.doi.org/10.1055/s-2008-1047721.6.Adani GL, Baccarani U, Risaliti A, Bresadola F, Della Rocca G, Viale P. Rhabdomyolysis due toLamivudine administration in a liver transplant recipient. Am J Transplant. 2005;5(3):634. PubMed PMID:15707423.http://dx.doi.org/10.1111/j.1600-6143.2005.00691.x.7.Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive CareMed. 2001;27(5):803–11.PubMed PMID: 11430535.http://dx.doi.org/10.107/s001340100878.8.Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11(8):1553–61.PubMed PMID: 10906171.9.Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med.1988;148(7):1553–7. PubMed PMID: 3382301.http://dx.doi.org/10.1001/archinte.1988.0038007005901510.Daher EDF, Silva Júnior GB da, Brunetta DM, Pontes LB, Bezerra GP. Rhabdomyolysis and acute renalfailure after strenuous exercise and alcohol abuse: case report and literature review. Sao Paulo Med J.2005;123(1):33–7. PubMed PMID: 15821814.http://dx.doi.org/10.1590/S1516-31802005000100008.11.Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol.1990;10(1):49–52. PubMed PMID: 2343880.http://dx.doi.org/10.1159/000168053.

Downloads

Published

2022-03-08

Issue

Vol. 6 No. 3 (2014): July-September 2014

Section

Articles

License

Copyright (c) 2020 Knowledge Kingdom Publishing

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.